NCT02736318View on ClinicalTrials.gov

OD-PHOENIX in Talus Osteochondral Lesion

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 27, 2017

Primary Completion Date

September 7, 2021

Study Completion Date

September 7, 2021

Conditions
Talus Osteochondral Defect
Interventions
BIOLOGICAL

OD-PHOENIX

Decellularized, freeze-dried, irradiated osteochondral allograft

Trial Locations (2)

2100

AZ Monica, Antwerp

1528001

Poriya Medical Center, Tiberias

Sponsors
All Listed Sponsors
lead

TBF Genie Tissulaire

INDUSTRY

NCT02736318 - OD-PHOENIX in Talus Osteochondral Lesion | Biotech Hunter | Biotech Hunter